Patent ID: 11944688
Assignee: SUTURA THERAPEUTICS LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 13:
14. The method of claim 1, wherein the BFL comprises:, , a residue of succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate, where Z is, , and Y is a covalent bond to the N-terminus of the StaP or the StiP;, , a residue of N-α-maleimidoacet-oxysuccinimide ester, where Z is, , and Y is a covalent bond to the N-terminus of the StaP or the StiP;, , a residue of N-β-maleimidopropyl-oxysuccinimide ester, where Z is, , and Y is a covalent bond to the N-terminus of the StaP or the StiP;, , a residue of N-γ-aleimidobutyryl-oxysuccinimide ester, where Z is, , and Y is a covalent bond to the N-terminus of the StaP or the StiP;, , a residue of N-δ-maleimidovaleryl-oxysuccinimide ester, where Z is, , and Y is a covalent bond to the N-terminus of the StaP or the StiP;, , a residue of N-ε-malemidocaproyl-oxysuccinimide ester, where Z is, , and Y is a covalent bond to the N-terminus of the StaP or the StiP;, , a residue of succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxy-(6-amidocaproate),, where Z is, , and Y is a covalent bond to the N-terminus of the StaP or the StiP;, , a residue of disuccinimidyl gluterate, where Z is not present;, or,, , a residue of disuccinimidyl-cyclohexl-1,4-diester, where Z is not present.